And across these different histologies, we have found that the most common tumor that we are treating or see on trials is prostate cancer. So WOLVERINE was based on that. We looked at all randomized ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

Researchers have discovered a new approach to prostate cancer treatment by combining immunotherapy with PIM1 kinase ...

"The interaction between inherited genetic factors and the timing of mutations in the tumor's DNA is central to understanding ...

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

Researchers at Keck Medicine of USC are part of a national, multisite clinical trial to evaluate a minimally invasive water ...

A new study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined ...

Researchers at University of Arizona Cancer Center used a double-pronged approach to reduce tumor growth in tissue samples of ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.